Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Unitree Robotics has released a bionic 7-axis dexterous robotic arm, priced from 9,900 yuan.
2026-08-20
Unitree Robotics has released a bionic 7-axis dexterous robotic arm, priced from 9,900 yuan.
Back
Other News
2026-08-20
Fed minutes said staff expect H2 overall inf to ease—largely driven by expected declines in retail gasoline—and for core inf to slow modestly. Staff project real GDP growth next year slightly above potential, with financial conditions and AI-related
Fed minutes said staff expect H2 overall inf to ease—largely driven by expected declines in retail gasoline—and for core inf to slow modestly. Staff project real GDP growth next year slightly above potential, with financial conditions and AI-related investment providing support; unemployment is forecast to remain near staff’s estimate of the long-run rate this year, edge down next year and fall slightly below the long-run rate by 2028. Compared with June projections, staff’s outlook for economic activity is a touch weaker, reflecting recent softer-than-expected data. Staff flagged sizable uncertainty from geopolitics and unclear economic effects of AI investment and adoption. Overall, risks to employment and real GDP are tilted to the downside while inf risks are tilted to the upside, including the risk that inf proves more persistent than staff anticipate.
2026-08-20
The A-share biotech vaccine sector continued to rise, with CSPC Pharmaceutical Innovation hitting the daily limit. Previously, many other stocks, including Serli Medical, Hepalink, Zhifei Biological, Jindike, and Wantai Biological, had also hit the d
The A-share biotech vaccine sector continued to rise, with CSPC Pharmaceutical Innovation hitting the daily limit. Previously, many other stocks, including Serli Medical, Hepalink, Zhifei Biological, Jindike, and Wantai Biological, had also hit the daily limit, while Dongfulong and Kangtai Biological rose by more than 15%.
Chat with us
, powered by
LiveChat